GB767788A
(en)
|
1953-12-28 |
1957-02-06 |
Schering Corp |
Polyiodinated phenyl fatty acid compounds and process for their manufacture
|
US3211610A
(en)
|
1961-09-29 |
1965-10-12 |
Merck & Co Inc |
Benzoic acid ester derivatives for treating coccidiosis and method of using same
|
US3444232A
(en)
|
1966-05-18 |
1969-05-13 |
Squibb & Sons Inc |
O-alkyl or phenylalkyl benzohydroxamic acids
|
GB1359560A
(en)
|
1972-02-25 |
1974-07-10 |
Merck & Co Inc |
Preparation of pyrrylsalicylic acid
|
US4036951A
(en)
|
1973-03-12 |
1977-07-19 |
Synergistics, Inc. |
Ultra-violet filtration with certain aminosalicylic acid esters
|
FR2440353A1
(fr)
|
1978-11-03 |
1980-05-30 |
Science Union & Cie |
Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
|
US4348223A
(en)
|
1980-12-05 |
1982-09-07 |
Ppg Industries, Inc. |
N-Alkyl-N-[3-(alkoxyalkyl)phenyl]-2-haloacetamide herbicides
|
DE3164618D1
(en)
|
1980-12-22 |
1984-08-09 |
Schering Ag |
3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them
|
JPS58194814A
(ja)
|
1982-05-11 |
1983-11-12 |
Nippon Shinyaku Co Ltd |
免疫調節作用を有する薬剤
|
IL69282A
(en)
|
1982-09-02 |
1988-06-30 |
Euro Celtique Sa |
Method for the carboxylation of potassium phenoxide with carbon dioxide
|
GB8302708D0
(en)
|
1983-02-01 |
1983-03-02 |
Efamol Ltd |
Pharmaceutical and dietary composition
|
EP0279096B1
(en)
|
1987-02-05 |
1993-07-07 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Benzyl ether compound and process for producing the same
|
AU1388388A
(en)
|
1987-04-01 |
1988-10-06 |
Dak-Laboratoriet A/S |
Benzoic acid derivatives and use thereof
|
ATE113209T1
(de)
|
1988-05-05 |
1994-11-15 |
Tillotts Pharma Ag |
Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten.
|
EP0554291B2
(en)
|
1990-10-22 |
2010-10-20 |
Centre For Digestive Diseases Pty Ltd |
Treatment of non-inflammatory bowel disorders
|
US5519014A
(en)
|
1990-10-22 |
1996-05-21 |
Borody; Thomas J. |
Treatment of non-inflammatory and non-infectious bowel disorders
|
US5262549A
(en)
|
1991-05-30 |
1993-11-16 |
Polaroid Corporation |
Benzpyrylium dyes, and processes for their preparation and use
|
WO1993019053A1
(fr)
|
1992-03-17 |
1993-09-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Derive de depsipeptide, production et utilisation
|
US5302751A
(en)
|
1992-01-21 |
1994-04-12 |
Ethyl Corporation |
Profen resolution
|
EP0604641B1
(en)
|
1992-06-30 |
2002-03-20 |
SHAPIRO, Howard, K. |
Use of a combination containing an amine or amine-related derivative of benzoic acid and an amino-polysaccharide in the manufacture of a medicament for the treatment of inflammatory diseases
|
US5594151A
(en)
|
1994-01-28 |
1997-01-14 |
Prolinx, Inc. |
Phenylboronic acid complexing reagents derived from aminosalicylic acid
|
EP0759750A4
(en)
|
1994-05-11 |
1998-05-27 |
Howard K Shapiro |
PREPARATIONS FOR TREATING CHRONIC FLAMMABLE DISEASES
|
US5594015A
(en)
|
1994-06-22 |
1997-01-14 |
Regents Of The University Of California |
Thiazolidine derivatives for the treatment of psoriasis
|
CA2215160A1
(en)
|
1995-03-28 |
1996-10-03 |
Maria-Helena Joris Jozef Verlinden |
Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
|
GB9600464D0
(en)
|
1996-01-09 |
1996-03-13 |
Smithkline Beecham Plc |
Novel method
|
GB9617001D0
(en)
|
1996-08-13 |
1996-09-25 |
Tillotts Pharma Ag |
Oral composition
|
DE19647582A1
(de)
|
1996-11-18 |
1998-05-20 |
Hoechst Ag |
Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
US7098025B1
(en)
|
1997-07-25 |
2006-08-29 |
Ligand Pharmaceuticals Incorporated |
Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
|
WO1999015520A1
(fr)
|
1997-09-19 |
1999-04-01 |
Ono Pharmaceutical Co., Ltd. |
Composes de benzene fusionnes ou non fusionnes
|
AU1911999A
(en)
|
1997-12-12 |
1999-06-28 |
Penn State Research Foundation, The |
Methods and compositions for treating diabetes
|
US7015249B1
(en)
|
1997-12-12 |
2006-03-21 |
Purdue Research Foundation |
Methods and compositions for treating diabetes
|
FR2773075B1
(fr)
|
1997-12-31 |
2000-05-05 |
Cird Galderma |
Utilisation d'activateurs de ppar-gamma en dermatologie
|
US6114382A
(en)
|
1998-11-11 |
2000-09-05 |
Moretti; Itagiba G. |
Methods for treating inflammatory bowel disease
|
US6326364B1
(en)
|
1999-02-08 |
2001-12-04 |
Cedars-Sinai Medical Center |
Use of 5-aminosalicylates as antimicrobial agents
|
FR2791671B1
(fr)
|
1999-04-01 |
2001-05-11 |
Oreal |
Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation
|
US20040034067A1
(en)
|
1999-04-15 |
2004-02-19 |
Macphee Colin Houston |
Novel method of treatment
|
GB9908647D0
(en)
|
1999-04-15 |
1999-06-09 |
Smithkline Beecham Plc |
Novel compounds
|
GB9914371D0
(en)
|
1999-06-18 |
1999-08-18 |
Smithkline Beecham Plc |
Novel compounds
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
AU7995300A
(en)
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
US7736661B1
(en)
|
2000-03-07 |
2010-06-15 |
Avon Products, Inc |
Method of treating skin conditions
|
CN1267408C
(zh)
|
2000-04-19 |
2006-08-02 |
纽若泰克有限公司 |
预防中枢神经系统急慢性损伤中神经变性的化合物,组合物和方法
|
ATE407919T1
(de)
|
2000-05-29 |
2008-09-15 |
Kyorin Seiyaku Kk |
Substituierte phenylpropionsäure-derivate
|
US7049342B2
(en)
|
2000-05-29 |
2006-05-23 |
Kyorin Pharmaceutical Co., Ltd. |
Substituted phenylpropionic acid derivatives
|
DE60115465T2
(de)
|
2000-08-29 |
2006-08-03 |
Nobex Corp. |
Immunoregulierende verbindungen, deren derivate und ihre verwendung
|
AU2002222574A1
(en)
|
2000-12-05 |
2002-06-18 |
Kyorin Pharmaceutical Co. Ltd. |
Substituted carboxylic acid derivatives
|
US7312247B2
(en)
|
2001-03-27 |
2007-12-25 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
FR2822955B1
(fr)
|
2001-03-27 |
2003-10-03 |
Chru Lille |
Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
|
WO2002085123A1
(en)
|
2001-04-18 |
2002-10-31 |
Merck & Co., Inc. |
Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
|
CA2354921A1
(en)
|
2001-05-24 |
2002-11-24 |
Yasuo Konishi |
Drug evolution: drug design at hot spots
|
WO2003033456A1
(en)
|
2001-10-16 |
2003-04-24 |
Dr. Reddy's Laboratories Ltd. |
NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS
|
WO2003043569A2
(en)
|
2001-11-16 |
2003-05-30 |
Nutrition 21, Inc. |
Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
WO2003045383A1
(en)
*
|
2001-11-26 |
2003-06-05 |
Arachnova Therapeutics Ltd. |
Use of ppar activators for the treatment of pulmonary fibrosis
|
UA82835C2
(en)
|
2001-12-03 |
2008-05-26 |
Reddys Lab Ltd Dr |
?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
|
US20030113815A1
(en)
|
2001-12-19 |
2003-06-19 |
Pfizer Inc. |
Canine peroxisome proliferator activated receptor gamma
|
WO2003053974A1
(en)
|
2001-12-21 |
2003-07-03 |
Dr. Reddy's Laboratories Ltd. |
Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US20030220374A1
(en)
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
US20040115127A1
(en)
|
2002-04-12 |
2004-06-17 |
Wright Samuel D. |
Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
|
US8492438B2
(en)
|
2002-04-26 |
2013-07-23 |
Asan Laboratories Company (Cayman), Limited |
Treatment skin disorders
|
WO2003093498A1
(en)
|
2002-04-29 |
2003-11-13 |
The Ohio State University |
Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic
|
DE10250080A1
(de)
|
2002-10-25 |
2004-05-13 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
US20060159648A1
(en)
|
2003-02-17 |
2006-07-20 |
Davis Adrian F |
Novel therapeutic method and compositions for topical administration
|
GB0303609D0
(en)
|
2003-02-17 |
2003-03-19 |
Glaxo Group Ltd |
Novel therapeutic method and compositions
|
US20060177444A1
(en)
|
2003-03-20 |
2006-08-10 |
Tatsuo Horizoe |
Concomitant drug as therapeutic agent for inflammatory bowel disease
|
US7981915B2
(en)
*
|
2003-04-30 |
2011-07-19 |
Beth Israel Deaconess Medical Center |
Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
|
CA2527861A1
(en)
|
2003-07-21 |
2005-02-10 |
Applied Research Systems Ars Holding N.V. |
Alkynyl aryl carboxamides
|
GB2422782A
(en)
|
2003-10-21 |
2006-08-09 |
Inspire Pharmaceuticals Inc |
Non-nucleotide compositions and method for treating pain
|
US20070093476A1
(en)
|
2003-10-28 |
2007-04-26 |
Bhunia Debnath |
Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
|
FR2862870A1
(fr)
|
2003-12-01 |
2005-06-03 |
Galderma Res & Dev |
Utilisation d'activateurs de recepteurs ppar en cosmetique et dermatologie.
|
WO2005055933A2
(en)
|
2003-12-03 |
2005-06-23 |
Smithkline Beecham Corporation |
Treatment of psoriasis with rosiglitazone
|
US7417037B2
(en)
|
2004-01-20 |
2008-08-26 |
The Board Of Regents Of The University Of Oklahoma |
Compositions and methods of treatment for inflammatory diseases
|
WO2005084658A1
(en)
|
2004-03-04 |
2005-09-15 |
Arakis Ltd. |
Derivatives of actarit and their therapeutic use
|
US20050277693A1
(en)
|
2004-06-10 |
2005-12-15 |
Dr. Reddy's Laboratories Limited |
Basic salts and monohydrates of certain alpha, beta-propionic acid derivative
|
PE20060594A1
(es)
|
2004-09-09 |
2006-08-18 |
Novartis Ag |
Composicion farmaceutica que contiene un agonista de ppar
|
AU2005289453A1
(en)
|
2004-09-27 |
2006-04-06 |
Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health |
Modulating MxA expression
|
US20060286046A1
(en)
|
2005-01-05 |
2006-12-21 |
Haber C Andrew |
Skin care compositions
|
EP1719543A1
(en)
|
2005-05-04 |
2006-11-08 |
Asan Labs., Ltd. |
Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
|
US20060270635A1
(en)
|
2005-05-27 |
2006-11-30 |
Wallace John L |
Derivatives of 4- or 5-aminosalicylic acid
|
ITRM20050389A1
(it)
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
|
ITRM20050390A1
(it)
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
|
US20070093524A1
(en)
|
2005-10-25 |
2007-04-26 |
Wyeth |
5-Lipoxygenase modulators
|
DE102005061472A1
(de)
|
2005-12-22 |
2007-07-05 |
Saltigo Gmbh |
Verfahren zur Herstellung von enantiomerenangereicherten 2-Alkoxy-3-phenylpropionsäuren
|
WO2007096148A1
(en)
|
2006-02-23 |
2007-08-30 |
Lipid Nutrition B.V. |
Immunoregulation
|
US7645801B2
(en)
|
2007-01-29 |
2010-01-12 |
Alaven Pharmaceutical Llc |
Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
|
IE20070129A1
(en)
*
|
2007-02-28 |
2008-12-24 |
Giuliani Int Ltd |
Ppar-gamma agonists stimulate enteric defensin expression
|
US8796282B2
(en)
|
2007-03-28 |
2014-08-05 |
Case Western Reserve University |
Method of treating dermatological disorders
|
WO2009025854A1
(en)
|
2007-08-22 |
2009-02-26 |
Burnham Institute For Medical Research |
Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases
|
IE20070928A1
(en)
*
|
2007-12-21 |
2009-09-30 |
Giuliani Int Ltd |
Multi target ligands
|
ITMI20072429A1
(it)
*
|
2007-12-24 |
2009-06-25 |
Giuliani Int Ltd |
Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
|
US8030520B2
(en)
|
2008-03-31 |
2011-10-04 |
Saltigo Gmbh |
Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide
|
US20090264520A1
(en)
|
2008-04-21 |
2009-10-22 |
Asha Lipid Sciences, Inc. |
Lipid-containing compositions and methods of use thereof
|
FR2938338B1
(fr)
|
2008-11-13 |
2012-10-05 |
Galderma Res & Dev |
Modulateurs de l'acetyl-coenzyme a acyltransferase 1 ou 2 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
|
UA107562C2
(uk)
|
2008-12-05 |
2015-01-26 |
|
Спосіб лікування псоріазу
|
ES2630044T3
(es)
|
2009-02-16 |
2017-08-17 |
Nogra Pharma Limited |
Compuestos de alquilamido y usos de los mismos
|
EP2298321A1
(en)
|
2009-08-26 |
2011-03-23 |
Nordic Pharma |
Novel pharmaceutical compositions for treating IBD
|
BR112013019360A2
(pt)
|
2011-01-28 |
2017-03-28 |
A Shaver William |
ingredientes, componente seco de formulação oral de baixo teor de cloreto farmaceuticamente aceitável para limpeza de cólon, solução de base de reposição de eletrólito aquosa para uso em lavagem colônica, métodos para limpar os intestinos de paciente, para preparar solução aquosa para limpeza do cólon e para aumentar substancialmente o paladar de limpador de cólon e kits para evacuação do cólon.
|
EP2731605A4
(en)
|
2011-07-15 |
2015-02-25 |
Sla Pharma Ag |
PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION
|
US9491942B2
(en)
|
2011-10-17 |
2016-11-15 |
The Regents Of The University Of California |
Methods for assessing repellant quality of organic materials and methods and compositions for repelling arthropods
|
WO2013064153A1
(en)
|
2011-10-31 |
2013-05-10 |
Claus Selch Larsen |
Prodrugs of non- steroid anti - inflammatory agents (nsaids)
|
US9044304B2
(en)
|
2011-12-23 |
2015-06-02 |
Alcon Lensx, Inc. |
Patient interface with variable applanation
|
KR102067848B1
(ko)
|
2012-02-09 |
2020-01-17 |
노그라 파마 리미티드 |
섬유증의 치료 방법
|
CA2870490A1
(en)
|
2012-04-18 |
2013-10-24 |
Nogra Pharma Limited |
Methods of treating lactose intolerance
|
WO2013168438A1
(ja)
|
2012-05-10 |
2013-11-14 |
国立大学法人岩手大学 |
ラクターゼ活性を有するタンパク質、該タンパク質をコードする遺伝子、該遺伝子を含有する組み換えベクター、形質転換体、及びその製造方法並びに用途
|
IN2014DN10214A
(ja)
|
2012-06-01 |
2015-08-07 |
Nogra Pharma Ltd |
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
EP2861580B1
(en)
|
2012-06-07 |
2018-04-25 |
Georgia State University Research Foundation, Inc. |
Seca inhibitors and methods of making and using thereof
|
US20150250749A1
(en)
|
2012-09-13 |
2015-09-10 |
Nogra Pharma Limited |
Methods of treating hair related conditions
|
CN104736149A
(zh)
|
2012-09-13 |
2015-06-24 |
诺格拉制药有限公司 |
抑制毛发生长的方法
|
WO2014150377A1
(en)
|
2013-03-15 |
2014-09-25 |
Embry-Riddle Aeronautical University, Inc. |
Electrically coupled counter-rotation for gas turbine compressors
|
AU2014243102B2
(en)
|
2013-03-26 |
2018-04-26 |
Lipid Therapeutics Gmbh |
Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis
|
KR101423005B1
(ko)
|
2013-10-17 |
2014-07-28 |
강윤식 |
장 세정용 조성물
|
CN105566153B
(zh)
|
2014-10-14 |
2019-05-31 |
中国医学科学院药物研究所 |
偶氮苯衍生物及其制法和药物组合物与用途
|
WO2016154730A1
(en)
|
2015-04-02 |
2016-10-06 |
University Health Network |
Gut anti-inflammatory agents for regulation of high blood glucose levels
|
CA2986611C
(en)
|
2015-06-15 |
2023-10-03 |
Nmd Pharma Aps |
Compounds for use in treating neuromuscular disorders
|
WO2017046343A1
(en)
|
2015-09-17 |
2017-03-23 |
Nogra Pharma Limited |
Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
|
WO2017093444A1
(en)
|
2015-12-01 |
2017-06-08 |
Nogra Pharma Limited |
Compositions for oral administration in the treatment of inflammatory bowel disease
|
EP3419616A1
(en)
|
2016-02-26 |
2019-01-02 |
Nogra Pharma Limited |
Methods of treating lactose intolerance
|
US20220000818A1
(en)
|
2019-01-25 |
2022-01-06 |
Nogra Pharma Limited |
Compositions for use in preventing acne
|
US11905232B2
(en)
|
2019-02-08 |
2024-02-20 |
Nogra Pharma Limited |
Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
|
US11903592B2
(en)
|
2021-05-10 |
2024-02-20 |
DePuy Synthes Products, Inc. |
Data modules for surgical instruments
|